Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
Purity:
95.20%
CAS Number:
[1262787-83-6]
Target:
Akt|||ERK|||EGFR|||Survivin|||HER|||PARP
T76796
T76796
* VAT and and shipping costs not included. Errors and price changes excepted
